Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02619656 · ClinicalTrials.gov registry record · NA
A Trial of Supplemental CO2 Versus Room Air in Percutaneous Endoscopic Gastrostomy
A NA study of Pneumoperitoneum, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT02619656 is a NA study of Pneumoperitoneum that has completed, run by University of Utah. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02619656, a NA study of Pneumoperitoneum, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that using carbon dioxide for PEG placement versus using room air will decrease post-procedure pneumoperitoneum as well as improve post-procedure bloating/pain, and waist circumference.
Conditions Studied
Interventions
- PROCEDURE CO2 insufflation
- PROCEDURE Ambient air insufflation
Study Locations (1)
Utah
- University of Utah SOM - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-04 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02619656
The ClinicalTrials.gov registry entry for NCT02619656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pneumoperitoneum appearing as the primary indexed condition, and to 2 interventions - of which CO2 insufflation is the first listed.
NCT02619656 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT02619656 about?
NCT02619656 is a clinical study titled "A Trial of Supplemental CO2 Versus Room Air in Percutaneous Endoscopic Gastrostomy". The investigators hypothesize that using carbon dioxide for PEG placement versus using room air will decrease post-procedure pneumoperitoneum as well as improve post-procedure bloating/pain, and waist circumference.
What is the current status of trial NCT02619656?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2012-04. Estimated completion is 2015-06.
What conditions does trial NCT02619656 study?
This clinical trial studies the following conditions: Pneumoperitoneum.
What interventions are being tested in trial NCT02619656?
The interventions under investigation include: CO2 insufflation (PROCEDURE), Ambient air insufflation (PROCEDURE).
Who is sponsoring clinical trial NCT02619656?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02619656 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumoperitoneum
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.